Drug Shortage Report for BREVICON 0.5/35 TABLETS (21-DAY PACK)
Report ID | 206521 |
Drug Identification Number | 02187086 |
Brand name | BREVICON 0.5/35 TABLETS (21-DAY PACK) |
Common or Proper name | Brevicon |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | NORETHINDRONE ETHINYL ESTRADIOL |
Strength(s) | 0.5MG 0.035MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 21's |
ATC code | G03AA |
ATC description | HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2023-10-06 |
Estimated end date | 2023-10-27 |
Actual end date | 2023-10-25 |
Shortage status | Resolved |
Updated date | 2023-10-26 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2023-10-26 | French | Compare |
v4 | 2023-10-26 | English | Compare |
v3 | 2023-10-07 | English | Compare |
v2 | 2023-10-06 | French | Compare |
v1 | 2023-10-06 | English | Compare |
Showing 1 to 5 of 5